SHARON MOHALE: Open Payments
NPI 1134397797 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 70 payments from 19 companies in 2025. Trend: 2023 $2,575 · 2024 $2,335 · 2025 $1,511
Food & beverage: $1,402Education: $109
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $298 |
| ABBVIE INC. | 18 | $260 |
| Amgen Inc. | 15 | $221 |
| Janssen Biotech, Inc. | 3 | $142 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| UCB, Inc. | 2 | $80 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $59 |
| GENZYME CORPORATION | 1 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: NEMLUVIO, SKYRIZI, Otezla, TREMFYA, Bimzelx, DUPIXENT, Zoryve, COSENTYX.
Industry payments across CA — which companies pay providers there.
